Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia trachomatis | 2 | 2025 | 70 | 0.910 |
Why?
|
| Chlamydia Infections | 2 | 2025 | 200 | 0.890 |
Why?
|
| Women's Health | 1 | 2025 | 160 | 0.850 |
Why?
|
| Regeneration | 1 | 2021 | 32 | 0.700 |
Why?
|
| Stem Cells | 1 | 2021 | 152 | 0.650 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 183 | 0.600 |
Why?
|
| Myocardium | 1 | 2021 | 263 | 0.600 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 247 | 0.580 |
Why?
|
| Mitochondria | 3 | 2026 | 523 | 0.540 |
Why?
|
| Aging | 2 | 2026 | 783 | 0.320 |
Why?
|
| Microscopy | 1 | 2026 | 35 | 0.240 |
Why?
|
| Mitochondria, Muscle | 1 | 2025 | 25 | 0.230 |
Why?
|
| GTP Phosphohydrolases | 1 | 2025 | 34 | 0.220 |
Why?
|
| Periodontitis | 1 | 2025 | 62 | 0.220 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2025 | 92 | 0.210 |
Why?
|
| Mitochondrial Proteins | 1 | 2025 | 118 | 0.210 |
Why?
|
| Endothelium, Vascular | 1 | 2025 | 263 | 0.200 |
Why?
|
| Kidney | 1 | 2026 | 372 | 0.200 |
Why?
|
| Oxidative Stress | 2 | 2026 | 1003 | 0.200 |
Why?
|
| Nitric Oxide | 1 | 2025 | 386 | 0.190 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 316 | 0.190 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 39 | 0.170 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 35 | 0.170 |
Why?
|
| Tissue Engineering | 1 | 2021 | 75 | 0.170 |
Why?
|
| Cell Differentiation | 1 | 2021 | 638 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2025 | 2157 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 512 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 1001 | 0.140 |
Why?
|
| Trichomonas Vaginitis | 1 | 2017 | 5 | 0.130 |
Why?
|
| Vaginosis, Bacterial | 1 | 2017 | 8 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 518 | 0.130 |
Why?
|
| Humans | 8 | 2026 | 43102 | 0.130 |
Why?
|
| Gonorrhea | 1 | 2017 | 24 | 0.130 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2017 | 174 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 1092 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 432 | 0.100 |
Why?
|
| Reactive Oxygen Species | 2 | 2026 | 532 | 0.100 |
Why?
|
| Female | 3 | 2025 | 24698 | 0.080 |
Why?
|
| Oleanolic Acid | 1 | 2025 | 6 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2026 | 210 | 0.060 |
Why?
|
| Sarcopenia | 1 | 2025 | 15 | 0.060 |
Why?
|
| Male | 4 | 2026 | 23409 | 0.060 |
Why?
|
| Mice | 2 | 2026 | 6644 | 0.050 |
Why?
|
| Animals | 3 | 2026 | 16992 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2024 | 9 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2024 | 19 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2024 | 44 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2024 | 54 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 665 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 307 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 1869 | 0.040 |
Why?
|
| Inflammation | 1 | 2025 | 758 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 1596 | 0.040 |
Why?
|
| Exercise | 1 | 2025 | 692 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 749 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 2853 | 0.030 |
Why?
|
| Apoptosis | 1 | 2025 | 1568 | 0.030 |
Why?
|
| Gardnerella vaginalis | 1 | 2017 | 2 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2023 | 968 | 0.030 |
Why?
|
| Trichomonas vaginalis | 1 | 2017 | 9 | 0.030 |
Why?
|
| Empirical Research | 1 | 2017 | 8 | 0.030 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2017 | 16 | 0.030 |
Why?
|
| Office Visits | 1 | 2017 | 28 | 0.030 |
Why?
|
| Case Management | 1 | 2017 | 24 | 0.030 |
Why?
|
| India | 1 | 2017 | 108 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2676 | 0.030 |
Why?
|
| Hospitals | 1 | 2017 | 117 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 12222 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 13872 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1604 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 8214 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 6081 | 0.010 |
Why?
|